Abstract
Coronavirus disease (COVID-19), first reported in December 2019 in Wuhan, China, has spread all over the world in a short time and was declared as a pandemic by the World Health Organization (WHO). During COVID-19 pandemic, chest computed tomography (CT) imaging has become an important tool with high sensitivity for diagnosis due to the low positive rate of the real-time reverse-transcriptase polymerase chain reaction (RT-PCR). Furthermore, the chest CT has played an important role in the diagnosis of underlying pulmonary lesions. In this case report, we present a patient who was admitted to the emergency department with fever, cough and left shoulder pain, and was subsequently diagnosed with both COVID-19 and pneumothorax following chest CT and RT-PCR test. Key Words: COVID-19, Coronavirus, Pneumothorax, Tomography.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Anticoagulants / therapeutic use
-
Antiviral Agents / therapeutic use
-
Azithromycin / therapeutic use
-
Betacoronavirus
-
COVID-19
-
Coronavirus / genetics
-
Coronavirus / isolation & purification*
-
Coronavirus Infections / complications
-
Coronavirus Infections / diagnosis*
-
Coronavirus Infections / drug therapy
-
Cough / etiology
-
Enoxaparin / therapeutic use
-
Female
-
Fever / etiology
-
Humans
-
Hydroxychloroquine / therapeutic use
-
Lung / diagnostic imaging*
-
Male
-
Oseltamivir / therapeutic use
-
Pandemics / prevention & control
-
Pneumonia, Viral / complications
-
Pneumonia, Viral / diagnosis*
-
Pneumonia, Viral / drug therapy
-
Pneumothorax / diagnostic imaging*
-
Pneumothorax / etiology
-
Reverse Transcriptase Polymerase Chain Reaction
-
SARS-CoV-2
-
Tomography, X-Ray Computed
-
Treatment Outcome
-
Young Adult
Substances
-
Anti-Bacterial Agents
-
Anticoagulants
-
Antiviral Agents
-
Enoxaparin
-
Oseltamivir
-
Hydroxychloroquine
-
Azithromycin